Some health care providers in China have stopped welcoming representatives of multinational drugmakers in their offices since Chinese police accused some drugmakers of bribery. Growth in the sector has slowed as some drugmakers have scaled back marketing activities and dropped sales quotas for the quarter.
Big Pharma hits closed doors in China
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|